Robert Royce, PhD
Implicitly denigrating the other chaps (or ladies) in health care? In the mother country, despite a mandate to compete, it simply isn’t done.
Medication Management
Thomas Reinke
Report says half of all insurers are not taking advantage of rebates for drugs delivered through the medical benefit
The Formulary Files
Krishna Rutvij Patel, Pharm D
Plan Watch
Frank Diamond
The insurer hopes two recently approved drugs —­ Belviq and Qsymia — will help people who do not get results from diet and exercise
Tomorrow's Medicine
Thomas Morrow, MD
Eloctate allows for significantly longer time between infusions
News & Commentary
News & Commentary
Frank Diamond

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report